AAAAAA
Results:
1-16
|
Results: 16
Authors:
Hubner, RA
Kubota, E
Casley, DJ
Johnston, CI
Burrell, LM
Citation: Ra. Hubner et al., In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat, J HYPERTENS, 19(5), 2001, pp. 941-946
Authors:
Cao, ZM
Burrell, LM
Tikkanen, I
Bonnet, F
Cooper, ME
Gilbert, RE
Citation: Zm. Cao et al., Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats, KIDNEY INT, 60(2), 2001, pp. 715-721
Authors:
Feuerstein, M
Marshall, L
Shaw, WS
Burrell, LM
Citation: M. Feuerstein et al., Multicomponent intervention for work-related upper extremity disorders, J OCCUP REH, 10(1), 2000, pp. 71-83
Authors:
Burrell, LM
Risvanis, J
Johnston, CI
Naitoh, M
Balding, LC
Citation: Lm. Burrell et al., Vasopressin receptor antagonism - a therapeutic option in heart failure and hypertension, EXP PHYSIOL, 85, 2000, pp. 259S-265S
Authors:
Burrell, LM
Droogh, J
in't Veld, OM
Rockell, MD
Farina, NK
Johnston, CI
Citation: Lm. Burrell et al., Antihypertensive and antihypertrophic effects of omapatrilat in SHR, AM J HYPERT, 13(10), 2000, pp. 1110-1116
Authors:
Fraser, TB
Turner, SW
Wen, C
Li, M
Burrell, LM
Whitworth, JA
Citation: Tb. Fraser et al., Vasopressin V-1A receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat, CLIN EXP PH, 27(11), 2000, pp. 866-870
Authors:
Farina, NK
Johnston, CI
Burrell, LM
Citation: Nk. Farina et al., Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs, J HYPERTENS, 18(6), 2000, pp. 749-755
Authors:
Burrell, LM
Farina, NK
Balding, LC
Johnston, CI
Citation: Lm. Burrell et al., Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure, HYPERTENSIO, 36(6), 2000, pp. 1105-1111
Authors:
Burrell, LM
Johnston, CI
Citation: Lm. Burrell et Ci. Johnston, Clinical trials of ACE inhibitors: Pathogenetic insights and therapeutic advances, V CH MO CAR, 1, 2000, pp. 191-200
Authors:
Sampey, DB
Burrell, LM
Widdop, RE
Citation: Db. Sampey et al., Vasopressin V-2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive rats, AM J P-REG, 45(3), 1999, pp. R872-R879
Authors:
Feuerstein, M
Burrell, LM
Miller, VI
Lincoln, A
Huang, GD
Berger, R
Citation: M. Feuerstein et al., Clinical management of carpal tunnel syndrome: A 12-year review of outcomes, AM J IND M, 35(3), 1999, pp. 232-245
Authors:
Dean, R
Edmondson, SR
Burrell, LM
Bach, LA
Citation: R. Dean et al., Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction, J HIST CYTO, 47(5), 1999, pp. 649-659
Authors:
Risvanis, J
Naitoh, M
Johnston, CI
Burrell, LM
Citation: J. Risvanis et al., In vivo and in vitro characterisation of a nonpeptide vasopressin V-1A andV-2 receptor antagonist (YM087) in the rat, EUR J PHARM, 381(1), 1999, pp. 23-30
Authors:
Power, JM
Raman, J
Dornom, A
Farish, SJ
Burrell, LM
Tonkin, AM
Buxton, B
Alferness, CA
Citation: Jm. Power et al., Passive ventricular constraint amends the course of heart failure: a studyin an ovine model of dilated cardiomyopathy, CARDIO RES, 44(3), 1999, pp. 549-555
Authors:
Jandeleit-Dahm, K
Burrell, LM
Kanazawa, M
Casley, D
Jackson, B
Johnston, CI
Citation: K. Jandeleit-dahm et al., Effects of neutral endopeptidase inhibition in the rat remnant kidney model, KIDNEY BL P, 21(6), 1998, pp. 419-424
Authors:
Yu, HCM
Burrell, LM
Black, MJ
Wu, LL
Dilley, RJ
Cooper, ME
Johnston, CI
Citation: Hcm. Yu et al., Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats, CIRCULATION, 98(23), 1998, pp. 2621-2628
Risultati:
1-16
|